Bluebird Bio Inc. sell StockNews.com
Start price
02.11.24
/
50%
€0.44
Target price
02.11.25
-
Performance (%)
-16.32%
End price
03.11.25
-
Summary
This prediction is currently being closed. The price of Bluebird Bio Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.32%. StockNews_com has a follow-up prediction for Bluebird Bio Inc. where he still thinks Bluebird Bio Inc. is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bluebird Bio Inc. | - | - | - |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% |
Comments by StockNews_com for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for BLUE provided by MarketBeat
In the thread Trading Bluebird Bio Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten